LC-MS can provide strong evidence that a sample contains a compound with the expected molecular mass. However, an intact-mass match alone may not prove the complete amino-acid sequence, distinguish every structural isomer, establish purity, measure vial content, or confirm sterility and endotoxin status.
LC-MS Peptide Identity: How Laboratories Confirm Peptides
In addition, LC-MS peptide identity testing helps laboratories check whether a sample contains a molecule with the expected mass. This guide explains charge states, mass reconstruction, measured and calculated mass, adducts, oxidation, mass error, and the limits of intact-mass testing.
For example, LC-MS peptide identity testing combines liquid LC separation with mass mass testing. First, the LC step separates sample parts. Next, the mass spectrometer measures charged ions. Finally, the analyst compares the measured mass pattern with the expected peptide.
However, a correct intact mass does not prove every part of the sequence. Therefore, a strong report should show the charge states, mass error, raw spectrum, reconstructed result, and the exact structure used for comparison.
LC-MS Peptide Identity: What Is LC-MS?
However, LC-MS stands for liquid LC separation–mass mass testing. It combines two lab techniques:
- Therefore, Liquid LC separation separates compounds in a sample.
- Moreover, Mass mass testing measures ions according to their mass-to-charge ratio.
As a result, together, these techniques allow a laboratory to separate a mixture, observe when each component leaves the LC separation column, and collect mass information about those components.
Likewise, for peptide analysis, LC-MS is often used to answer questions such as:
- By contrast, does the sample contain a component with the expected molecule mass?
- In addition, does the main LC peak correspond to the claimed peptide?
- However, are oxidation products, truncations, adducts, or other variants detectable?
- For example, are multiple peptide-related components present?
- Therefore, does the sample require more detailed sequence-confirmation testing?
Moreover, Mass mass testing gives useful evidence about peptide mass, variants, and chemical changes. In addition, FDA materials describe LC-MS and LC-MS/MS as useful tools for peptide identity and impurity analysis. See the FDA guidance on protein and peptide study.
Why Combine Liquid LC separation With Mass mass testing?
By contrast, a peptide sample may contain more than one component. In addition, it can include the intended peptide, synthesis-related impurities, degradation products, counterions, salts, solvents, or other materials.
However, sending the entire mixture directly into a mass spectrometer can produce overlapping signals that are difficult to interpret. For example, liquid LC separation helps by separating some of those components before they enter the mass spectrometer.
When did the component elute?
Therefore, liquid LC separation provides retention-time information and helps separate the target from other detectable compounds.
What mass-to-charge signals the instrument detected?
Moreover, mass mass testing measures ion signals that can be interpreted to estimate the molecule mass of the eluting component.
As a result, the combined data are more informative than either result alone. Likewise, a laboratory can evaluate whether the LC main peak produces the expected mass pattern rather than merely assuming that the largest HPLC peak is the target compound.
By contrast, This is why LC-MS is an important supporting method for understanding how to read a peptide COA. HPLC may show that one peak dominates the chromatogram, while mass mass testing helps determine whether that peak has the mass expected for the claimed peptide.
What Does a Mass Spectrum Show?
However, a mass spectrum is usually displayed as a graph containing many vertical lines or peaks.
Mass-to-charge ratio
For example, The horizontal axis the axis label shows m/z, meaning mass divided by charge.
Signal intensity
Therefore, the vertical axis shows the relative strength or abundance of each detected ion signal.
Moreover, a mass-spectrum peak is not the same thing as a LC peak.
- As a result, A LC peak represents detector response over retention time.
- Likewise, A mass-spectral peak represents ions detected at a particular mass-to-charge ratio.
By contrast, one LC peak may produce several mass-spectral peaks because the same peptide can carry different numbers of electrical charges.
Understanding Mass-to-Charge Ratio
In addition, Mass spectrometers do not usually measure the neutral molecule weight of a peptide directly. They measure the mass-to-charge ratio of charged ions.
For example, The letter m represents mass, while z represents the ion’s charge.
Therefore, consider a simplified peptide with a neutral mass of about 3,000 daltons:
| Ion form | Approximate charge | Approximate m/z region |
|---|---|---|
| Singly charged | +1 | about 3,001 |
| Doubly charged | +2 | about 1,501 |
| Triply charged | +3 | about 1,001 |
| Quadruply charged | +4 | about 751 |
Moreover, These values are simplified because the added protons have mass. However, the example shows why a 3,000-dalton peptide may appear near an m/z of 1,001 rather than at 3,000: the molecule may be carrying three positive charges.
What Are Charge States?
Likewise, Before a mass spectrometer can detect a peptide, the peptide must be converted into a charged ion. A common technique for peptide LC-MS is electrospray ion formation, often abbreviated ESI.
In addition, during positive-mode electrospray ion formation, peptide molecules often gain one or more protons. However, the resulting ions may be written as:
- For example, [M + H]+ — one added proton and a +1 charge
- Therefore, [M + 2H]2+ — two added protons and a +2 charge
- Moreover, [M + 3H]3+ — three added protons and a +3 charge
- As a result, [M + 4H]4+ — four added protons and a +4 charge
Likewise, The letter M represents the neutral peptide molecule. The superscript indicates the net charge.
Why one peptide can produce several signals
In addition, peptides often contain several sites capable of accepting protons. However, depending on sequence, size, solvent conditions, mobile-phase makeup, instrument settings, and shape, different molecules from the same sample may receive different numbers of protons.
For example, The instrument may therefore detect a family of related signals called a charge-state envelope.
Therefore, these signals do not always represent four different peptides. Moreover, they may represent four differently charged forms of the same peptide.
As a result, charge-state distributions can be affected by solvents and ion formation conditions, which is why experienced analysts evaluate the entire related pattern rather than relying on one isolated signal.
Multiple charge states can strengthen interpretation
Likewise, when several related charge states independently calculate back to the same neutral mass, the result is generally more convincing than an interpretation based on a single weak or isolated signal.
What Is mass reconstruction?
By contrast, a raw electrospray mass spectrum may show multiple charge states, isotope clusters, adducts, background signals, and noise. In addition, to a non-specialist, the graph may look like a collection of unrelated peaks.
However, mass reconstruction is a software-assisted process that uses the measured charge-state pattern to estimate the peptide’s neutral molecule mass.
A simplified example
For example, suppose related signals appear at positions consistent with +2, +3, and +4 ions. Therefore, mass reconstruction software can calculate the neutral mass represented by each signal and combine the evidence into a reconstructed mass peak.
Moreover, the report may then display:
- As a result, measured reconstructed mass: 3,002.41 Da
- calculated mass: 3,002.39 Da
- Mass difference: 0.02 Da
Likewise, this is easier to understand than asking the reader to interpret each multiply charged raw ion manually.
mass reconstruction is not perfect
By contrast, mass reconstruction depends on settings selected by software or the analyst, including:
- Expected mass range
- Expected charge-state range
- Signal-to-noise threshold
- isotope-model settings
- Retention-time region
- Adduct handling
- Peak-merging rules
- Background subtraction
In addition, poor settings can produce missing masses, false masses, merged species, or misleadingly clean results. However, technical literature from instrument manufacturers specifically cautions that mass reconstruction can produce incorrect conclusions when poor assumptions or settings are applied.
A reconstructed mass is a processed result
For example, a trustworthy report should retain the raw spectrum, identify the analyzed retention-time region, and provide enough information to understand how the reconstructed result was produced.
measured Mass Versus calculated Mass
Therefore, lC-MS identity reports often compare two values:
calculated mass
Moreover, the mass calculated from the expected amino-acid sequence and specified chemical changes.
measured mass
As a result, the mass estimated from the instrument data after charge assignment and, when applicable, mass reconstruction.
How calculated mass the software calculates
Likewise, the calculated mass is based on the molecule makeup expected from the proposed structure. By contrast, the calculation must account for more than simply adding individual amino-acid masses.
In addition, depending on the peptide, the calculation may need to include:
- The complete amino-acid sequence
- However, loss of water during peptide-bond formation
- Free or modified N-terminus
- For example, free, amidated, or otherwise modified C-terminus
- Disulfide-bond formation
- acetyl-group addition
- Amidation
- Lipid or fatty-acid attachments
- Labels or linkers
- Other expected chemical changes
Average mass versus single-isotope mass
Therefore, Reports may use either an average molecule mass or a single-isotope mass. These are not the same.
| Mass type | Meaning | Common relevance |
|---|---|---|
| single-isotope mass | As a result, calculated using the exact mass of the most abundant stable isotope of each element. | Likewise, often used for smaller peptides and high-detail level isotope-resolved measurements. |
| Average mass | By contrast, calculated using the naturally weighted average atomic mass of each element. | In addition, often used for larger molecules or unresolved isotope envelopes. |
However, a comparison is only meaningful when the measured and calculated values use the same mass convention.
What a close match means
For example, when the measured mass closely matches the correctly calculated calculated mass, the result supports the presence of a molecule with the expected elemental makeup or nominal molecule mass.
Therefore, that is useful identity evidence—but it is not automatically complete structural proof.
Understanding Mass Error and Parts per Million
Moreover, no mass measurement is perfectly exact. As a result, laboratories therefore report how far the measured value differs from the calculated value.
Likewise, the difference may be expressed in:
- Daltons, abbreviated Da
- Mass units
- By contrast, Parts per million, abbreviated ppm
Example
Assume:
- calculated mass: 4,000.000 Da
- measured mass: 4,000.020 Da
In addition, the difference is 0.020 Da, equivalent to about 5 ppm.
However, whether that difference is acceptable depends on:
- For example, the type of mass spectrometer
- Instrument detail level
- setup check status
- Therefore, whether single-isotope or average mass is being used
- Signal intensity
- Sample complexity
- mass reconstruction quality
- Moreover, the validated method’s acceptance criteria
More decimal places do not automatically mean greater certainty
As a result, a report can display many decimal places even when the instrument, isotope detail level, setup check, or mass reconstruction does not justify that degree of precision. Likewise, the meaningful question is whether the result falls within a scientifically suitable and documented tolerance.
What Are Adducts?
By contrast, A peptide ion does not always enter the mass spectrometer with only added protons. It may carry another small ion or molecule along with it. This attached species is called an adduct.
For example, common positive-mode adducts may involve:
- Sodium
- Potassium
- Ammonium
- Solvent molecules
- Mobile-phase components
- Other salts or contaminants
Sodium adducts
Therefore, A common example is a sodium-associated ion. Instead of detecting only [M + H]+, the spectrum may also contain [M + Na]+.
As a result, because sodium is heavier than a proton, the sodium-adduct signal appears at a higher mass than the protonated form.
Likewise, For a singly charged ion, replacing a proton with sodium produces a difference of about 22 daltons. For multiply charged ions, that mass difference is divided by the charge when viewed on the raw m/z scale.
Adducts do not always mean a second peptide
In addition, a peptide, its sodium adduct, and its potassium adduct may produce several nearby signals even though they originate from the same underlying peptide molecule.
However, extensive adduct formation can complicate interpretation by:
- For example, spreading signal intensity across several ion forms
- Therefore, reducing the intensity of the main protonated signal
- Creating additional reconstructed peaks
- Moreover, overlapping with genuine modified species
- As a result, making automated charge assignment more difficult
Likewise, technical mass-mass testing workflows often account for protonated and sodiated species during data processing, and solvent-related adducts are routinely recognized during intact-mass analysis.
Oxidation and Other Mass-Shifting changes
By contrast, peptides can undergo chemical changes during synthesis, purification, storage, shipping, sample preparation, or analysis. In addition, some changes alter the molecule mass in predictable ways.
Oxidation
However, Oxidation often produces an approximate mass increase of +16 Da for each added oxygen atom.
For example, certain amino acids are more more likely to oxidation than others, including:
- Methionine
- Tryptophan
- Cysteine
- Histidine under certain conditions
- Therefore, tyrosine under certain oxygen-related conditions
Moreover, a reconstructed spectrum might therefore show:
- Main peptide mass: M
- As a result, singly oxidized form: M + 16 Da
- Likewise, doubly oxidized form: M + 32 Da
By contrast, lC-MS workflows are often used to assess oxidation variants and other product-quality attributes.
Other possible mass changes
| Change | Typical mass effect | Important limit |
|---|---|---|
| Oxidation | In addition, about +16 Da per oxygen | However, intact mass may not reveal which residue was oxidized. |
| a small chemical change | about +0.984 Da | For example, may be difficult to resolve without sufficient mass accuracy and separation. |
| acetyl-group addition | about +42 Da | Therefore, the location of acetyl-group addition may remain uncertain. |
| Loss of water | about −18 Da | Moreover, can represent in-source breaking into fragments or a chemical variant. |
| Loss of ammonia | about −17 Da | As a result, may occur during ion formation or breaking into fragments. |
| Sodium association | Likewise, about +22 Da relative to proton replacement | By contrast, usually an adduct rather than a bonded sequence change. |
| Sequence truncation | In addition, depends on the missing residue or residues | However, different truncations can sometimes have similar nominal masses. |
For example, the exact interpretation depends on whether the signal represents a true bonded change, an ion-source artifact, an adduct, a fragment, or a separate impurity.
Why a Mass Match Alone May Not Prove the Complete Sequence
Therefore, one of the most common misunderstandings about LC-MS is the belief that matching the expected intact molecule mass automatically proves the complete amino-acid sequence.
It does not.
Moreover, intact-mass analysis answers a limited but important question:
Does the analyzed component have a measured molecule mass consistent with the proposed molecule?
As a result, it does not always answer:
Are all amino acids present in the correct order, with every bond, change, and 3D-form feature in the correct location?
Different sequences can have the same mass
Likewise, two peptides containing the same amino acids in a different order have the same total molecule formula and therefore the same calculated intact mass.
For example:
By contrast, these sequences contain the same collection of residues but in different orders. In addition, an intact-mass measurement alone may not distinguish them.
Leucine and isoleucine have the same mass
However, leucine and isoleucine are same-formula structures. For example, they have the same elemental makeup and the same residue mass.
Therefore, replacing leucine with isoleucine—or isoleucine with leucine—may therefore produce no change in intact molecule mass.
Moreover, even tandem mass mass testing often requires additional lab strategy to distinguish these isomeric residues conclusively.
D-amino acids and L-amino acids can have the same mass
As a result, d- and L-forms of an amino acid have the same elemental makeup and molecule mass. Likewise, conventional intact-mass analysis cannot establish 3D-form orientation.
By contrast, a peptide containing an incorrect stereoisomer may therefore match the expected intact mass.
Some structural arrangements are same-mass
In addition, The term same-mass describes compounds with the same or nearly the same measured mass.
Possible examples include:
- However, different amino-acid orders with the same makeup
- Leucine and isoleucine substitutions
- D- and L-amino-acid substitutions
- For example, different change locations with the same total mass
- Different disulfide-bond arrangements
- Therefore, different structural or positional isomers
Intact mass may not locate a change
Moreover, if a peptide gains one oxygen atom, intact mass may show a +16 Da shift. As a result, that result supports oxidation but does not always identify which amino-acid residue was oxidized.
Likewise, the same principle applies to many other changes. By contrast, intact mass may reveal that a mass change occurred without establishing its exact location.
Co-elution can complicate the result
In addition, two components with similar retention behavior may enter the mass spectrometer at nearly the same time. However, their ion signals may overlap, particularly when one component is much more abundant than the other.
For example, a strong expected-mass signal does not prove that no other peptide-related material was present in the same LC region.
Expected mass is evidence—not complete structural proof
Therefore, an intact-mass match strongly supports identity when combined with LC separation, suitable standards, expected charge states, and good-quality spectra. Moreover, complete sequence confirmation may require tandem mass mass testing, peptide mapping, amino-acid analysis, NMR, 3D-form analysis, or other supporting methods.
As a result, This distinction is central to understanding why you cannot identify a peptide by looking at it. Appearance provides essentially no reliable molecule-identity information, while LC-MS provides meaningful evidence—but even LC-MS must be interpreted according to what the specific test was designed to prove.
What Is LC-MS/MS?
By contrast, LC-MS/MS, also called tandem mass mass testing, goes beyond measuring an intact precursor ion.
In addition, in a simplified tandem-MS workflow:
- However, the liquid chromatograph separates the sample.
- For example, the first mass-analysis stage selects an ion of interest.
- Therefore, the selected ion the instrument fragments.
- Moreover, a second mass-analysis stage measures the fragment ions.
- As a result, the fragment pattern the analyst compares with the expected sequence.
Likewise, because peptide breaking into fragments often breaks peptide bonds, the resulting fragment-ion series can provide information about amino-acid order.
Sequence coverage
By contrast, A tandem-MS report may state a percentage of sequence coverage. This describes how much of the proposed sequence the data support by identified fragment ions or mapped peptides.
However, sequence coverage should be interpreted carefully. For example, a high percentage is useful, but it does not automatically prove:
- Therefore, every peptide bond was directly confirmed
- Moreover, every leucine/isoleucine position was distinguished
- As a result, every residue has the correct 3D form
- Likewise, every change was localized without ambiguity
- By contrast, no low-level variant was present
In addition, FDA also describes LC-MS/MS as a powerful tool for studying peptide products and peptide-related impurities. Moreover, tandem MS can support sequence evidence by measuring fragment ions. See the FDA study guidance.
Intact Mass, Peptide Mapping, and Sequence Confirmation
| Testing approach | Main question answered | main limit |
|---|---|---|
| Intact LC-MS | Therefore, does the intact component have the expected molecule mass? | Moreover, may not prove amino-acid order, 3D form, or change location. |
| LC-MS/MS of intact peptide | As a result, do fragment ions support the proposed peptide sequence? | Likewise, fragment coverage may be incomplete or unclear. |
| enzyme-based peptide mapping | By contrast, do expected digestion fragments appear with expected masses and retention behavior? | In addition, depends on digestion completeness, coverage, and fragment uniqueness. |
| Amino-acid analysis | However, does the overall amino-acid makeup and quantity match expectations? | For example, usually does not establish the order of residues. |
| NMR spectroscopy | Therefore, does the molecule structure produce the expected nuclear-resonance pattern? | Moreover, can require large material and special interpretation. |
| Chiral analysis | As a result, are amino acids or components present in the expected 3D-form form? | Likewise, requires a specifically designed 3D-form method. |
Why This Matters for Thymosin Beta-4 and TB-500
By contrast, product names can be used inconsistently, particularly when a full-length peptide, a fragment, a modified analog, or a related research material is marketed under a familiar shorthand name.
In addition, a label stating “TB-500” does not independently establish whether the vial contains:
- Full-length Thymosin Beta-4
- However, a specific fragment associated with the TB-500 name
- A modified analog
- For example, a different peptide with a similar marketing name
- Therefore, a mixture or mislabeled compound
Moreover, lC-MS can help distinguish molecules with substantially different expected masses. However, the laboratory must compare the result with the correct calculated structure—not merely with a product name.
Likewise, a meaningful report should specify:
- By contrast, the exact amino-acid sequence being claimed
- The expected molecule formula
- The expected intact mass
- In addition, the terminal changes, if any
- The measured charge states
- The reconstructed mass
- The allowed mass tolerance
- However, whether tandem-MS sequence evidence was collected
For example, See Thymosin Beta-4 vs. TB-500 for a detailed explanation of why terminology, sequence, and molecule identity must be separated from marketing shorthand.
Does LC-MS Measure Peptide Purity?
Moreover, lC-MS can detect and study multiple components, but an LC-MS identity result should not automatically be interpreted as a complete purity result.
As a result, depending on the method, ion formation efficiency can vary dramatically between compounds. Likewise, one impurity may ionize strongly while another ionizes poorly or not at all under the selected conditions.
By contrast, mass-spectral signal intensity therefore does not always correspond directly to the physical quantity of each compound.
LC-MS mass match
In addition, shows that a detected component produced mass data consistent with the expected molecule.
HPLC or LC peak-area result
However, estimates the proportion of included LC detector response assigned to the main peak.
measured assay
For example, estimates how much target compound is present using setup check and an suitable reference standard.
LC-MS/MS mapping
Therefore, uses fragment-ion information to support the proposed amino-acid order and change locations.
Moreover, these tests answer related but different questions. As a result, a strong certificate of analysis clearly separates identity, purity, and assay rather than presenting one result as proof of all three.
Common LC-MS Report Terms
| Term | Plain-language meaning |
|---|---|
| m/z | Likewise, the measured mass of an ion divided by the number of charges it carries. |
| Charge state | By contrast, the number of positive or negative electrical charges on an ion. |
| Charge envelope | In addition, a family of signals representing differently charged forms of the same molecule. |
| measured mass | However, the molecule mass estimated from experimental data. |
| calculated mass | For example, the mass calculated from the proposed molecule structure. |
| mass reconstruction | Therefore, software processing that converts multiple charge-state signals into an estimated neutral mass. |
| single-isotope mass | Moreover, mass calculated using the exact masses of specific isotopes. |
| Average mass | As a result, mass calculated using naturally weighted average atomic masses. |
| Mass accuracy | Likewise, how closely the measured mass agrees with the expected mass. |
| ppm | By contrast, parts per million; a relative unit used to express mass error. |
| Adduct | In addition, a peptide ion associated with another ion or molecule, such as sodium. |
| Precursor ion | However, the selected intact or partially intact ion chosen for breaking into fragments. |
| Product ion | For example, a fragment ion produced from the selected precursor. |
| Sequence coverage | Therefore, the portion of a proposed sequence supported by identified fragments or mapped peptides. |
| Total ion chromatogram | Moreover, a chromatogram based on the summed mass-spectral ion signal over time. |
| Extracted ion chromatogram | As a result, a chromatogram showing signal for a selected mass or mass range over time. |
How to Review an LC-MS COA
Match the sample and batch
Likewise, confirm that the COA identifies the same product, sample, and batch shown on the vial or product page.
Find the claimed sequence
By contrast, the report should identify the exact sequence or structure used to calculate the calculated mass.
Check terminal changes
In addition, confirm whether the peptide has a free acid, amide, acetyl group, lipid attachment, or another change.
Compare mass conventions
However, make sure the measured and calculated results are both single-isotope or both average mass.
Review the raw charge states
For example, look for multiple logically related charge states rather than only a final reconstructed number.
Inspect the mass error
Therefore, check the difference in daltons or ppm and compare it with the laboratory’s documented tolerance.
Look for adduct assignments
Moreover, determine whether neighboring peaks were identified as sodium, potassium, solvent, or other adducts.
Look for change peaks
As a result, check for oxidation, a small chemical change, truncation, or other reported mass-shifted variants.
Confirm what type of LC-MS was performed
Likewise, distinguish intact-mass confirmation from tandem-MS sequencing or peptide mapping.
Do not confuse identity with purity
By contrast, a correct mass does not establish that the entire sample consists only of that compound.
Do not confuse identity with vial content
In addition, lC-MS identity testing does not automatically prove the labeled milligram amount.
Verify the laboratory
However, look for verifiable laboratory information, test dates, analysts, report identifiers, and verification features.
Red Flags in an LC-MS Identity Report
Mass and Sequence Red Flags
- For example, Only the final mass number the report shows. The raw spectrum and charge-state evidence are missing.
- Moreover, The report does not list the expected sequence. It is impossible to confirm whether the calculated mass was calculated from the correct structure.
- Likewise, calculated and measured masses use different conventions. Average and single-isotope masses may be incorrectly compared.
- In addition, No mass tolerance the report states. The report declares a match without defining what qualifies as acceptable.
- For example, The product name the report treats as a molecule structure. A marketing name does not define sequence, termini, changes, or molecule formula.
Reporting and Batch Red Flags
- Moreover, Adducts are presented as proof of additional compounds. Sodium or potassium-associated ions may be alternate forms of the same peptide.
- Likewise, Unexpected peaks reports omit without explanation. Oxidized, truncated, or adducted species may be hidden from the summary.
- In addition, An intact-mass result is called complete sequence confirmation. Intact mass alone usually cannot establish every residue’s order, location, and 3D form.
- For example, The report claims identity, purity, and quantity from one mass match. These are separate lab questions requiring suitable methods.
- Moreover, The same spectrum appears on unrelated batches. Reused or generic reports may not represent the tested batch.
often Asked Questions
How to Interpret the Main Results
How This Section Fits Into an LC-MS Report
Likewise, does a matching LC-MS mass prove peptide identity?
By contrast, it provides strong supporting evidence that a detected component has the expected molecule mass. However, intact mass alone may not prove the complete amino-acid sequence, 3D form, change location, or absence of same-mass alternatives.
However, why does one peptide appear at several m/z values?
For example, electrospray ion formation can add different numbers of protons to different molecules of the same peptide. Therefore, the resulting +2, +3, +4, or other charge states appear at different m/z values.
Moreover, what does mass reconstruction do?
As a result, mass reconstruction software recognizes related charge-state signals and converts them into an estimated neutral molecule mass.
Likewise, what is the difference between measured and calculated mass?
By contrast, calculated mass the software calculates from the proposed chemical structure. In addition, measured mass the instrument measures experimentally from the mass-mass testing data.
However, what does a +16 Da peak usually mean?
For example, a +16 Da shift often suggests oxidation through the addition of one oxygen atom, although the interpretation must be confirmed in the context of the method and spectrum.
Therefore, what is a sodium adduct?
Moreover, it is an ion in which the peptide is associated with sodium. As a result, it may create an additional mass-spectral signal without representing a different peptide sequence.
Likewise, can LC-MS distinguish leucine from isoleucine?
By contrast, not by intact mass alone. In addition, leucine and isoleucine have the same elemental makeup and mass. However, special breaking into fragments or supporting lab techniques may be required.
For example, can LC-MS identify D-amino acids?
Therefore, conventional intact-mass testing cannot distinguish D- and L-amino acids because they have the same mass. Moreover, a stereochemically selective method the method requires.
As a result, does LC-MS prove the amount of peptide in a vial?
Likewise, not unless the method is specifically designed and validated as a measured assay using suitable setup check and reference standards.
By contrast, does an LC-MS identity test prove 99% purity?
In addition, no. However, identity and purity are different measurements. For example, a sample may contain a correct-mass peptide along with other compounds.
LC-MS Peptide Identity Provides Strong Evidence, but Not Complete Proof
Therefore, lC-MS is one of the most useful techniques for evaluating peptide identity. Moreover, liquid LC separation separates sample components, while mass mass testing measures charged ions and helps determine whether the main component has the expected molecule mass.
As a result, a strong identity conclusion considers:
- Likewise, the exact claimed amino-acid sequence
- By contrast, expected terminal and side-chain changes
- measured charge states
- Raw and reconstructed spectra
- calculated and measured mass
- In addition, mass error and instrument tolerance
- Adducts and oxidation products
- However, possible truncations or related variants
- For example, whether tandem-MS sequence evidence was collected
Therefore, a close intact-mass match is meaningful evidence, but it should not be exaggerated. Moreover, molecules with different sequences or 3D form can sometimes share the same mass, and an identity match does not independently prove LC purity, vial content, sterility, endotoxin status, or suitability for any particular use.
As a result, the most trustworthy reports clearly state what the instrument measured, how the result was processed, and what conclusions the method can—and cannot—support.